振东制药: 关于调整回购股份价格上限的公告

Key Points - The company has adjusted the upper limit of the share repurchase price due to the recent increase in its stock price, reflecting confidence in its future development and value recognition [2][3] - The total amount for the share repurchase plan is set between RMB 50 million and RMB 100 million, with a maximum repurchase price of RMB 6 per share [2][3] - As of the announcement date, the company has repurchased 12,916,700 shares at an average price of RMB 3.51 per share, totaling RMB 51,025,218 [2][3] - The adjustment of the repurchase price limit is in compliance with relevant regulations and is aimed at ensuring the smooth implementation of the repurchase plan without adversely affecting the company's operations or financial status [3][4] - The decision to adjust the repurchase price limit was made without needing to submit it for shareholder approval, following the company's internal regulations [4]